Sulfonic acid derivative and its pharmaceutical application
AssigneeToray Industries, Inc.
InventorsKiyotaka Ohno, Atsushi Ohtake, Shintaro Nishio, Kazuhiro Hoshi, Shunji Tsukamoto
Life of this patent
Estimating the term…
Loading patent…
AssigneeToray Industries, Inc.
InventorsKiyotaka Ohno, Atsushi Ohtake, Shintaro Nishio, Kazuhiro Hoshi, Shunji Tsukamoto
Estimating the term…
The present invention discloses sulfonamide derivative represented by the following general formula: ##STR1## [wherein, R.sub.1 is (i) --COOR.sub.2 (where, R.sub.2 is (1) hydrogen, (2) a pharmacologically acceptable cation, or (3) an alkyl having 1 to 14 carbon atoms) or, (ii) --C(.dbd.O)--R.sub.3 (wherein, R.sub.3 represents an alkyl having 1 to 4 carbon atoms); A is (i) --(CH.sub.2)n-- (wherein, n represents an integer of 0 to 3), (ii) --CH.dbd.CH--, or the group: (iii) --O--C(R.sub.4) (R.sub.5)-- (wherein, R.sub.4 and R.sub.5 represent (1) hydrogen or (2) an alkyl having 1 to 4 carbon atoms, and R.sub.4 and R.sub.5 may be identical or different); and, w is NH or --O--], as well as a thromboxane A2 receptor antagonistic drug having said derivative for its active ingredient. Since the compound of the present invention has excellent thromboxane A2 receptor antagonistic action, it can be used as a thromboxane A2 receptor antagonist of high activity and long duration.
Sulfonic acid represented by formula I:
Sulfonic acid represented by formula I:
Dependencies are inferred from the claim text.